Buenos Aires Mácula

Ciudad Autonoma de Buenos Aires, Buenos Aires C1061AAE

0 studies enrolling now · 2 studies all time

What they study most

Obesity, Overweight, Type 2 Diabetes

Studies at this site

• Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide — Running, not enrolling
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed